Indication
Diarrhea predominant irritable bowel syndrome
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a chronic disorder of gut-brain interaction affecting the gastrointestinal system, primarily presenting in adolescents and adults with a higher prevalence in females. Read more about Diarrhea predominant irritable bowel syndrome
22 drugs 21 manufacturers
Drugs that treat it
Common Diarrhea predominant irritable bowel syndrome therapies.
ALOSETRON HCL
ALOSETRON HCL
LOTRONEX (alosetron HCl)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonDiarrhea-predominant irritable bowel syndrome (IBS-D) is a chronic disorder of gut-brain interaction affecting the gastrointestinal system, primarily presenting in adolescents and adults with a higher prevalence in females.
It is clinically characterized by recurrent abdominal pain related to defecation, accompanied by frequent, loose, or watery stools on more than 25% of bowel movement days without predominant constipation.
The underlying pathophysiology is multifactorial and involves dysregulated gut-brain signaling, accelerated intestinal transit, visceral hypersensitivity, altered gut microbiota, and increased intestinal mucosal permeability.
- nih.gov
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a chronic disorder of gut-brain interaction affecting the gastrointestinal system, primarily presenting in adolescents and adults with a higher prevalence in females The underlying pathophysiology is multifactorial and involves dysregulated gut-brain signaling, accelerated intestinal transit, visceral hypersensitivity, altered gut microbiota, and increased intestinal mucosal permeability
- merckmanuals.com
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a chronic disorder of gut-brain interaction affecting the gastrointestinal system, primarily presenting in adolescents and adults with a higher prevalence in females
- nih.gov
It is clinically characterized by recurrent abdominal pain related to defecation, accompanied by frequent, loose, or watery stools on more than 25% of bowel movement days without predominant constipation
- clinicasgastroenterologiademexico.com
It is clinically characterized by recurrent abdominal pain related to defecation, accompanied by frequent, loose, or watery stools on more than 25% of bowel movement days without predominant constipation The underlying pathophysiology is multifactorial and involves dysregulated gut-brain signaling, accelerated intestinal transit, visceral hypersensitivity, altered gut microbiota, and increased intestinal mucosal permeability
Personalize your experience
Follow Diarrhea predominant irritable bowel syndrome and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.